MitoGenetics, LLC
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2014 | $2 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jun 2013 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
MitoGenetics, LLC chose not to state its revenue in its newest notice of a funding round (May 2016).
SEC Form D · May 2016
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2016
That is all the official record says: MitoGenetics, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of MitoGenetics, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 99 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brad Saeger | Executive officer | May 2016 |
| Brian Minish | Executive officer | May 2016 |
| George Charles Stefano | Executive officer | May 2016 |
| Isaac Tessmer | Executive officer | May 2016 |
| Marcia Hendrickson | Executive officer | May 2016 |
| Nick Sershen | Executive officer | May 2016 |
| William Switzer | Executive officer | May 2016 |
| Evan W. Rayl | Executive officer | Mar 2014 |
| Isaac J. Tessmer | Executive officer | Mar 2014 |
| Ivan W. Paulson | Executive officer | Mar 2014 |
| Leon J. Schwartz | Executive officer | Mar 2014 |
| Steve W. Sershen | Executive officer | Mar 2014 |
| William W. Switzer | Executive officer | Mar 2014 |
| Brad Saeger | Director | May 2016 |
| E. Charles Brice | Director | May 2016 |
| George Charles Stefano | Director | May 2016 |
| Isaac Tessmer | Director | May 2016 |
| Marcia Hendrickson | Director | May 2016 |
| Mark Graczynski | Director | May 2016 |
| Max Charles Rogers | Director | May 2016 |
| Walt Bones | Director | May 2016 |
| William Switzer | Director | May 2016 |
| Brad W. Nelson | Director | Mar 2014 |
| Evan W. Rayl | Director | Mar 2014 |
| Isaac J. Tessmer | Director | Mar 2014 |
| Ivan W. Paulson | Director | Mar 2014 |
| Leon J. Schwartz | Director | Mar 2014 |
| Mark W. Atwood | Director | Mar 2014 |
| Mark W. Graczynski | Director | Mar 2014 |
| William W. Switzer | Director | Mar 2014 |